Global Hyperphosphatemia Treatment Market Report 2024

Hyperphosphatemia Treatment Global Market Report 2024 – By Product (Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Other products), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, Online stores) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Hyperphosphatemia Treatment Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Hyperphosphatemia Treatment Market Definition And Segments

Hyperphosphatemia treatment refers to a class of drugs that boost renal excretion to treat patients' hyperphosphatemia. The most efficient way to do this is through volume replenishment with saline and forced diuresis with a loop diuretic such as furosemide or bumetanide.

The main products in the hyperphosphatemia treatment market are sevelamer, calcium-based phosphate binders, iron-based phosphate binders, lanthanum carbonate, and others. The sevelamer market consists of sales of sevelamer products by entities (organizations, partnerships, and sole traders) that refer to phosphate binding medication used for the treatment of hyperphosphatemia in patients with chronic and kidney diseases. The hyperphosphatemia treatment is distributed through hospital pharmacies, retail pharmacies, and online stores. By dosage form, it is segmented into capsules, tablets, and syrups.

The hyperphosphatemia treatment market covered in this report is segmented –

1) By Product: Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Other products

2) By Distribution channel: Hospital Pharmacy, Retail Pharmacy, Online stores

The hyperphosphatemia treatment market size has grown rapidly in recent years. It will grow from $4.1 billion in 2023 to $4.61 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increased incidence of chronic kidney disease (CKD), growth in aging population, high prevalence of diabetes and hypertension, expansion of dialysis patient population, advances in medical research and diagnosis of hyperphosphatemia.

The hyperphosphatemia treatment market size is expected to see rapid growth in the next few years. It will grow to $7.54 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rise in lifestyle-related diseases contributing to hyperphosphatemia, continued growth in aging demographics, increasing awareness and diagnosis of hyperphosphatemia, expansion of emerging markets with high disease burden, higher prescription share of calcium-based phosphate binders in emerging countries. Major trends in the forecast period include advancements in hyperphosphatemia treatment technologies, integration of telehealth and remote patient monitoring, collaborations and partnerships for research and development, focus on patient education and lifestyle management in hyperphosphatemia, development of novel phosphate binders and therapies.

Sustainable Growth Of Hyperphosphatemia Treatment Market Amid Rising Chronic Disease Prevalence

The increase chronic diseases among patients is driving the growth of the hyperphosphatemia treatment market. Chronic diseases are non-communicable and require long-term care. A vast majority of chronic diseases can be categorized as cardiovascular diseases, chronic kidney disease, chronic respiratory conditions, hyperparathyroidism, diabetes, and cancer. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Furthermore, in February 2023, according to SingleCare Services LLC, a US-based healthcare savings platform, the prevalence of kidney diseases is increasing, and each year untreated kidney failure claims the lives of approximately 1 million individuals. There has been an increase in hyperphosphatemia among patients with end-stage renal disease (ESRD), thus contributing to an increase in demand for hyperphosphatemia treatment or drugs.

Evolving Dietary Habits And Their Impact On The Hyperphosphatemia Treatment Market

The increasing dietary modifications is expected to propel the growth of the hyperphosphatemia treatment market going forward. Dietary modifications refer to intentional changes made to a person's diet or eating habits in order to achieve specific health, nutritional, or lifestyle goals. Dietary modifications can play a significant role in the management of hyperphosphatemia, which can offer control over phosphate, prevent complications, reduce medication use, promote health, and improve quality of life. For instance, in June 2022, according to the Food Standards Agency (FSA), a UK-based government agency, eight out of ten people have changed their eating habits throughout the past 12 months. In 2021, 23% of adults in Scotland said that their diet had gotten worse since the epidemic, and 75% of respondents stated they knew they needed to make big adjustments to their diet in order to be healthier. Therefore, the increasing dietary modifications is driving the growth of the hyperphosphatemia treatment market.

Major companies operating in the hyperphosphatemia treatment market report are Sanofi SA, Akebia Therapeutics Inc., AMAG Pharmaceuticals Inc., Ardelyx Inc., Astellas Pharma Inc., Fresenius Medical Care AG & Co. KGaA, Keryx Biopharmaceuticals Inc., Lupin Limited, Shire plc, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Ultragenyx Pharmaceutical Inc., Unicycive Therapeutics Inc., Vifor Pharma Management Ltd., Zeria Pharmaceutical Co. Ltd., Abbott Laboratories, Amgen Inc., AstraZeneca plc, B. Braun Melsungen AG, Baxter International Inc., Beckman Coulter Inc., Cleveland Clinic, DaVita Inc., Encompass Health Corporation, FMC Corporation, Hospital Corporation of America Healthcare Inc., Kyowa Kirin Pharmaceuticals Co. Ltd., Mayo Clinic, Medtronic plc, OPKO Health Inc., Roche Diagnostics Corporation, Siemens Healthineers AG, Sysmex Corporation, Tenet Healthcare Corporation, Thermo Fisher Scientific Inc., UnitedHealth Group Inc.

Rising Emphasis On Research And Development In Hyperphosphatemia Treatment Market

The increasing research and development activities are a key trend in the hyperphosphatemia treatment market. The company in hyperphosphatemia treatment are focused on research and development activities for the development of innovative therapies for the treatment of renal diseases and related chronic conditions. For instance, in May 2021, Alebund Pharmaceuticals, a Shanghai-based biopharmaceutical company, raised $60 million in a Series B round to accelerate its development activities of innovative drugs and solutions for the treatment of renal diseases, including hyperphosphatemia.

Increasing Focus On Product Development To Provide Reliable Services To Their Customers

Major companies operating in the hyperphosphatemia treatment market are focusing on innovative product development such as xphozah to drive revenues in their market. Xphozah is designed to treat hyperphosphatemia, characterized by excessive phosphorus causing calcium removal from bones and various body parts. For instance, in October 2023, Ardelyx Inc. a US-based biopharmaceutical company, got approval for Xphozah. This was approved to treat hyperphosphatemia, which removes calcium from bones and other body parts by excess phosphorus can result in brittle bones, joint pain, cramping muscles, and itchy skin. The medication has been approved by the FDA for use in patients who have not responded well to phosphate binder therapies, which are the condition's current standard of care, or who are intolerant to them.

Life Healthcare Group Enhances Renal Dialysis Capabilities With Acquisition Of Fresenius Medical Care Ag And Co. KGaA

In May 2023, Life Healthcare Group Holdings Limited, a South Africa-based healthcare services group, acquired Fresenius Medical Care AG and Co. KGaA for an undisclosed amount. This acquisition would enhance Life Healthcare’s acute and ongoing renal dialysis treatments offered in South Africa. With this acquisition, Life Healthcare has committed to playing a crucial role in ensuring the continuity of their current patient care plans. Fresenius Medical Care AG and Co. KGaA is a Germany-based company that manufactures drugs for hyperphosphatemia treatment.

North America was the largest region in the hyperphosphatemia treatment market in 2023.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperphosphatemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperphosphatemia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The hyperphosphatemia treatment market includes revenues earned by lowering the phosphate load and maintaining serum phosphorus levels within the normal range. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The hyperphosphatemia treatment market research report is one of a series of new reports from The Business Research Company that provides hyperphosphatemia treatment market statistics, including hyperphosphatemia treatment industry global market size, regional shares, competitors with a hyperphosphatemia treatment market share, detailed hyperphosphatemia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperphosphatemia treatment industry. This hyperphosphatemia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hyperphosphatemia Treatment Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $4.61 billion
Revenue Forecast In 2033 $7.54 billion
Growth Rate CAGR of 13.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Other products
2) By Distribution channel: Hospital Pharmacy, Retail Pharmacy, Online stores
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Sanofi SA; Akebia Therapeutics Inc.; AMAG Pharmaceuticals Inc.; Ardelyx Inc.; Astellas Pharma Inc.; Fresenius Medical Care AG & Co. KGaA; Keryx Biopharmaceuticals Inc.; Lupin Limited; Shire plc; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Ultragenyx Pharmaceutical Inc.; Unicycive Therapeutics Inc.; Vifor Pharma Management Ltd.; Zeria Pharmaceutical Co. Ltd.; Abbott Laboratories; Amgen Inc.; AstraZeneca plc; B. Braun Melsungen AG; Baxter International Inc.; Beckman Coulter Inc.; Cleveland Clinic; DaVita Inc.; Encompass Health Corporation; FMC Corporation; Hospital Corporation of America Healthcare Inc.; Kyowa Kirin Pharmaceuticals Co. Ltd.; Mayo Clinic; Medtronic plc; OPKO Health Inc.; Roche Diagnostics Corporation; Siemens Healthineers AG; Sysmex Corporation; Tenet Healthcare Corporation; Thermo Fisher Scientific Inc.; UnitedHealth Group Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Hyperphosphatemia Treatment Market Characteristics

    3. Hyperphosphatemia Treatment Market Trends And Strategies

    4. Hyperphosphatemia Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Hyperphosphatemia Treatment Market Size and Growth

    5.1. Global Hyperphosphatemia Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Hyperphosphatemia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Hyperphosphatemia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Hyperphosphatemia Treatment Market Segmentation

    6.1. Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Sevelamer

    Calcium-Based Phosphate Binders

    Iron-Based Phosphate Binders

    Lanthanum Carbonate

    Other products

    6.2. Global Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online stores

    7. Hyperphosphatemia Treatment Market Regional And Country Analysis

    7.1. Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Hyperphosphatemia Treatment Market

    8.1. Asia-Pacific Hyperphosphatemia Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Hyperphosphatemia Treatment Market

    9.1. China Hyperphosphatemia Treatment Market Overview

    9.2. China Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Hyperphosphatemia Treatment Market

    10.1. India Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Hyperphosphatemia Treatment Market

    11.1. Japan Hyperphosphatemia Treatment Market Overview

    11.2. Japan Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Hyperphosphatemia Treatment Market

    12.1. Australia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Hyperphosphatemia Treatment Market

    13.1. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Hyperphosphatemia Treatment Market

    14.1. South Korea Hyperphosphatemia Treatment Market Overview

    14.2. South Korea Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Hyperphosphatemia Treatment Market

    15.1. Western Europe Hyperphosphatemia Treatment Market Overview

    15.2. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Hyperphosphatemia Treatment Market

    16.1. UK Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Hyperphosphatemia Treatment Market

    17.1. Germany Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Hyperphosphatemia Treatment Market

    18.4. France Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.5. France Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Hyperphosphatemia Treatment Market

    19.7. Italy Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.8. Italy Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Hyperphosphatemia Treatment Market

    20.10. Spain Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.11. Spain Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Hyperphosphatemia Treatment Market

    21.1. Eastern Europe Hyperphosphatemia Treatment Market Overview

    21.2. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Hyperphosphatemia Treatment Market

    22.1. Russia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Hyperphosphatemia Treatment Market

    23.1. North America Hyperphosphatemia Treatment Market Overview

    23.2. North America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Hyperphosphatemia Treatment Market

    24.1. USA Hyperphosphatemia Treatment Market Overview

    24.2. USA Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Hyperphosphatemia Treatment Market

    25.1. Canada Hyperphosphatemia Treatment Market Overview

    25.2. Canada Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Hyperphosphatemia Treatment Market

    26.1. South America Hyperphosphatemia Treatment Market Overview

    26.2. South America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Hyperphosphatemia Treatment Market

    27.1. Brazil Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Hyperphosphatemia Treatment Market

    28.1. Middle East Hyperphosphatemia Treatment Market Overview

    28.2. Middle East Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Hyperphosphatemia Treatment Market

    29.1. Africa Hyperphosphatemia Treatment Market Overview

    29.2. Africa Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Hyperphosphatemia Treatment Market Competitive Landscape And Company Profiles

    30.1. Hyperphosphatemia Treatment Market Competitive Landscape

    30.2. Hyperphosphatemia Treatment Market Company Profiles

    30.2.1. Sanofi SA

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Akebia Therapeutics Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AMAG Pharmaceuticals Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Ardelyx Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Astellas Pharma Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Hyperphosphatemia Treatment Market Competitive Benchmarking

    32. Global Hyperphosphatemia Treatment Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Hyperphosphatemia Treatment Market

    34. Hyperphosphatemia Treatment Market Future Outlook and Potential Analysis

    34.1 Hyperphosphatemia Treatment Market In 2028 - Countries Offering Most New Opportunities

    34.2 Hyperphosphatemia Treatment Market In 2028 - Segments Offering Most New Opportunities

    34.3 Hyperphosphatemia Treatment Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: China, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: China, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: India, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: India, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: Japan, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: Japan, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: Australia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: Australia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: UK, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: UK, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Germany, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Germany, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: France, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: France, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Italy, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Italy, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Spain, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Spain, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Russia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Russia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: North America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: North America, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: USA, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: USA, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Canada, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Canada, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: South America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: South America, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Africa, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Africa, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Sanofi SA Financial Performance
  • Table 52: Akebia Therapeutics Inc. Financial Performance
  • Table 53: AMAG Pharmaceuticals Inc. Financial Performance
  • Table 54: Ardelyx Inc. Financial Performance
  • Table 55: Astellas Pharma Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: China, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: China, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: India, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: India, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: Japan, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: Japan, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: Australia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: Australia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: UK, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: UK, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Germany, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Germany, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: France, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: France, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Italy, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Italy, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Spain, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Spain, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Russia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Russia, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: North America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: North America, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: USA, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: USA, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Canada, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Canada, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: South America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: South America, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Africa, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Africa, Hyperphosphatemia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Sanofi SA Financial Performance
  • Figure 52: Akebia Therapeutics Inc. Financial Performance
  • Figure 53: AMAG Pharmaceuticals Inc. Financial Performance
  • Figure 54: Ardelyx Inc. Financial Performance
  • Figure 55: Astellas Pharma Inc. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024 – By Product (Endoscopic Thermal Devices, Other Products), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Gastrointestinal Devices Global Market Report 2024 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Medical Equipment Maintenance Global Market Report 2024 – By Service Type (Preventive Maintenance, Corrective Maintenance, Operational Maintenance), By Device (Imaging Equipment, Endoscopic Devices, Surgical Instruments, Electro-medical Equipment), By Technology (Multi-Vendor OEMs, Single-Vendor OEMs, Independent Service Organization, In-House Maintenance), By End User (Hospital, Diagnostic Imaging Centers, Dialysis Centers, Ambulatory Surgical Centers, Dental Clinics And Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Medication Adherence Global Market Report 2024 – By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology, Other Medications), By Application (Hospital, Retail Pharmacies, Long-Term Care Facilities, Mail-Order Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Dialysis Devices And Equipment Global Market Report 2024 – By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biosimilar Therapeutic Peptides Global Market Report 2024 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Endoscopy Devices And Equipment Global Market Report 2024 – By Product (Endoscope, Endoscopy Operative Devices, Endoscopy Visualization Systems), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hemodialysis And Peritoneal Dialysis Global Market Report 2024 – By Type (Hemodialysis, Short-Term Catheter, Chronic Catheter, Graft, Fistula, Peritoneal Dialysis), By Modality (Conventional, Daily (Day Time, Night Time)), By End User (Hospitals, Clinics, And Dialysis Centers, Home Dialysis) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the hyperphosphatemia treatment market?

Hyperphosphatemia treatment refers to a class of drugs that boost renal excretion to treat patients' hyperphosphatemia. The most efficient way to do this is through volume replenishment with saline and forced diuresis with a loop diuretic such as furosemide or bumetanide. For further insights on the image recognition market, request a sample here

How will the hyperphosphatemia treatment market drivers and restraints affect the hyperphosphatemia treatment market dynamics? What forces will shape the hyperphosphatemia treatment industry going forward?

The hyperphosphatemia treatment market major growth driver - sustainable growth of hyperphosphatemia treatment market amid rising chronic disease prevalence. For further insights on the image recognition market, request a sample here

What is the forecast market size or the forecast market value of the hyperphosphatemia treatment market ?

The hyperphosphatemia treatment market size has grown rapidly in recent years. It will grow from $4.1 billion in 2023 to $4.61 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increased incidence of chronic kidney disease (ckd), growth in aging population, high prevalence of diabetes and hypertension, expansion of dialysis patient population, advances in medical research and diagnosis of hyperphosphatemia. The hyperphosphatemia treatment market size is expected to see rapid growth in the next few years. It will grow to $7.54 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to rise in lifestyle-related diseases contributing to hyperphosphatemia, continued growth in aging demographics, increasing awareness and diagnosis of hyperphosphatemia, expansion of emerging markets with high disease burden, higher prescription share of calcium-based phosphate binders in emerging countries. Major trends in the forecast period include advancements in hyperphosphatemia treatment technologies, integration of telehealth and remote patient monitoring, collaborations and partnerships for research and development, focus on patient education and lifestyle management in hyperphosphatemia, development of novel phosphate binders and therapies. For further insights on the image recognition market, request a sample here

How is the hyperphosphatemia treatment market segmented?

The hyperphosphatemia treatment market is segmentedThe hyperphosphatemia treatment market covered in this report is segmented –
1) By Product: Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Other products
2) By Distribution channel: Hospital Pharmacy, Retail Pharmacy, Online storesFor further insights on the image recognition market, request a sample here

Which region has the largest share of the hyperphosphatemia treatment market? What are the other regions covered in the report?

North America was the largest region in the hyperphosphatemia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperphosphatemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the image recognition market, request a sample here.

Who are the major players in the hyperphosphatemia treatment market?

Major companies operating in the hyperphosphatemia treatment market report are Sanofi SA, Akebia Therapeutics Inc., AMAG Pharmaceuticals Inc., Ardelyx Inc., Astellas Pharma Inc., Fresenius Medical Care AG & Co. KGaA, Keryx Biopharmaceuticals Inc., Lupin Limited, Shire plc, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Ultragenyx Pharmaceutical Inc., Unicycive Therapeutics Inc., Vifor Pharma Management Ltd., Zeria Pharmaceutical Co. Ltd., Abbott Laboratories, Amgen Inc., AstraZeneca plc, B. Braun Melsungen AG, Baxter International Inc., Beckman Coulter Inc., Cleveland Clinic, DaVita Inc., Encompass Health Corporation, FMC Corporation, Hospital Corporation of America Healthcare Inc., Kyowa Kirin Pharmaceuticals Co. Ltd., Mayo Clinic, Medtronic plc, OPKO Health Inc., Roche Diagnostics Corporation, Siemens Healthineers AG, Sysmex Corporation, Tenet Healthcare Corporation, Thermo Fisher Scientific Inc., UnitedHealth Group Inc. For further insights on the image recognition market, request a sample here.

What are the key trends in the hyperphosphatemia treatment market?

Major trend in the hyperphosphatemia treatment market - rising emphasis on research and development in hyperphosphatemia treatment market. For further insights on the image recognition market, request a sample here.

What are the major opportunities in the hyperphosphatemia treatment market? What are the strategies for the hyperphosphatemia treatment market?

For detailed insights on the major opportunities and strategies in the hyperphosphatemia treatment market, request a sample here.

How does the hyperphosphatemia treatment market relate to the overall economy and other similar markets?

For detailed insights on hyperphosphatemia treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the hyperphosphatemia treatment industry?

For detailed insights on the mergers and acquisitions in the hyperphosphatemia treatment industry, request a sample here.

What are the key dynamics influencing the hyperphosphatemia treatment market growth? SWOT analysis of the hyperphosphatemia treatment market.

For detailed insights on the key dynamics influencing the hyperphosphatemia treatment market growth and SWOT analysis of the hyperphosphatemia treatment industry, request a sample here.